Clinical Trial Update: Role of Huachansu in Treating Hepatocellular Carcinoma and the Correlation With Na+/K+-ATPase [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating Huachansu for hepatocellular carcinoma and its association with Na+/K+-ATPase activity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Huachansu

Snippet

Sponsor: Fudan University | Conditions: Carcinoma, Hepatocellular | Phase 2 | Status: UNKNOWN